doi: 10.1007/s00125-006-0588-6
Proposals were advanced to exclude semaglutide, tirzepatide, and liraglutide from the 503B bulk drug substances list, further limiting large-scale production
According to the Summary of Product Characteristics (SmPC), treatment typically starts with 0.25 mg once weekly for four weeks, then increases to 0.5 mg once weekly, with further increases to 1 mg or 2 mg if needed for glycaemic control
Super Easy GLP-1 Diet Cookbook: A Complete 90-Day High-Protein Meal Plan for Lasting Weight Loss in Just 10 Minutes a Day Recipes to Control Cravings & Optimize Your Metabolism
Alternatives and Personalized Approaches to GLP-1 Therapy If depression or mood instability emerges during semaglutide treatment, options include dose reduction, switching to a different GLP-1 medication with different pharmacokinetics, or temporarily pausing therapy while addressing the underlying mood disorder with psychiatric support
Thompson, A